To study the effect of changing perfusion pressures on retinal and choroidal structure in central serous chorioretinopathy (CSC).
This prospective observational case series included seven healthy volunteers (14 eyes) and seven patients (14 eyes) with CSC. Each patient underwent spectral domain optical coherence tomography with enhanced depth imaging in the upright (sitting) and supine positions. Image segmentation focused on central macular thickness, subretinal fluid, total macular volume, choroidal thickness, and choriocapillaris thickness. Blood pressure and heart rate were measured in the upright and supine positions.
Choriocapillaris thickness was thicker in CSC participants (34.23 μm; range, 30.9–36.5 μm) compared with healthy controls (13.96 μm; range, 7.15–23.87 μm) (P ≤ 0.001). The choroid was similarly thicker in CSC participants (371.4 μm; range, 200.2–459.4 μm) compared with healthy controls (231.4 μm; range 161.8–287.5 μm) (P ≤ 0.001). Choroidal thickness increased in patients with CSC when transitioning from upright (371.4 μm) to supine (377.8 μm) (P ≤ 0.01). By contrast, there was an 11.97% decrease in choroid thickness in normal controls when transitioning from upright (231.4 μm) to supine (203.9 μm). There were no significant hemodynamic changes.
We demonstrated that choroidal thickness increased in response to increased perfusion pressures in patients with CSC and not in normal controls. These findings likely represent an autonomic dysregulation of choroidal blood flow in patients with CSC.
The authors demonstrate an inability of the central serous chorioretinopathy diseased choroid to regulate its thickness in response to increased perfusion pressures. This may represent an autonomic dysregulation of choroidal blood flow in patients with central serous chorioretinopathy.
*Eye Associates of New Mexico, Retina Center, Albuquerque, New Mexico;
†Department of Surgery, University of New Mexico School of Medicine, Albuquerque, New Mexico;
‡Eye Surgeons Associates, Bettendorf, Iowa;
§The Stephen A. Wynn Institute for Vision Research, University of Iowa, Iowa City Iowa;
¶Iowa Institute for Biomedical Imaging, Iowa City, Iowa;
**VitreoRetinal Surgery, PA, St. Paul, Minnesota;
††Retina Consultants of Southern California, Riverside, California; and
‡‡Department of Ophthalmology and Visual Sciences, Vitreoretinal Service, University of Iowa Hospitals and Clinics, Iowa City, Iowa.
Reprint requests: Christopher N. Roybal, MD, PhD, Eye Associates of New Mexico, Retina Center, 4411 The 25 way, Albuquerque, NM 87109; e-mail: email@example.com
None of the authors has any financial/conflicting interests to disclose.
All authors participated in study design, data collection, data analysis, and manuscript preparation.